Subtopic Deep Dive

FGF21 Metabolism Regulation
Research Guide

What is FGF21 Metabolism Regulation?

FGF21 metabolism regulation encompasses the molecular mechanisms controlling fibroblast growth factor 21 expression and signaling in hepatic lipid metabolism, glucose homeostasis, and energy balance during fasting, exercise, and PPARα activation.

FGF21 is primarily produced in the liver and regulated by PPARα under fasting conditions (Gälman et al., 2008, 491 citations). Key studies show PPARα directly induces hepatic FGF21 expression (Lundåsen et al., 2007, 373 citations). Neonatal hepatic FGF21 activates brown fat thermogenesis via PPARα in response to milk intake (Hondares et al., 2010, 362 citations). Over 2,000 papers explore FGF21 in metabolic contexts.

Curated Papers

Key Challenges

Why It Matters

FGF21 regulates hepatic gluconeogenesis and brain-liver crosstalk during prolonged fasting, maintaining glucose homeostasis (Liang et al., 2014, 286 citations). Acute exercise boosts FGF21 expression in mice and humans, enhancing energy homeostasis and offering therapeutic potential for type 2 diabetes (Kim et al., 2013, 280 citations). PPARα-FGF21 axis modulates JNK signaling for metabolic adaptation (Vernia et al., 2014, 184 citations). Fenofibrate activates FGF21/SIRT1 to prevent cardiac fibrosis in diabetic models (Zhang et al., 2016, 157 citations). These pathways position FGF21 as a target for obesity, diabetes, and NAFLD treatments.

Key Research Challenges

Tissue-Specific Regulation

FGF21 expression varies by metabolic state, complicating targeted therapies across liver, adipose, and brain tissues (Lundåsen et al., 2007). Hepatic dominance under fasting contrasts with exercise-induced muscle effects (Kim et al., 2013). Integrating multi-organ signaling remains unresolved (Liang et al., 2014).

PPARα Dependency Variability

PPARα drives basal FGF21 induction, but alternative pathways like FXR activation emerge in ketogenic states (Cyphert et al., 2012, 152 citations). Neonatal vs. adult responses differ, challenging uniform models (Hondares et al., 2010). Quantifying pathway crosstalk is key (Vernia et al., 2014).

Therapeutic Translation Gaps

Fasting-induced autophagy via FGF21-JMJD3 requires validation beyond rodents (Byun et al., 2020, 205 citations). Human exercise responses need longitudinal data (Kim et al., 2013). Diabetic cardiac benefits via fenofibrate-FGF21 demand clinical trials (Zhang et al., 2016).

Essential Papers

The Circulating Metabolic Regulator FGF21 Is Induced by Prolonged Fasting and PPARα Activation in Man

Cecilia Gälman, Tomas Lundåsen, Alexei Kharitonenkov et al. · 2008 · Cell Metabolism · 491 citations

PPARα is a key regulator of hepatic FGF21

Thomas Lundåsen, Mary C. Hunt, Lisa-Mari Nilsson et al. · 2007 · Biochemical and Biophysical Research Communications · 373 citations

Hepatic FGF21 Expression Is Induced at Birth via PPARα in Response to Milk Intake and Contributes to Thermogenic Activation of Neonatal Brown Fat

Elayne Hondares, Meritxell Rosell, Frank J. Gonzalez et al. · 2010 · Cell Metabolism · 362 citations

FGF21 Maintains Glucose Homeostasis by Mediating the Cross Talk Between Liver and Brain During Prolonged Fasting

Qingning Liang, Ling Zhong, Jialiang Zhang et al. · 2014 · Diabetes · 286 citations

Hepatic gluconeogenesis is a main source of blood glucose during prolonged fasting and is orchestrated by endocrine and neural pathways. Here we show that the hepatocyte-secreted hormone fibroblast...

Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans

Kook Hwan Kim, Seong‐Hun Kim, Young‐Ki Min et al. · 2013 · PLoS ONE · 280 citations

Fibroblast growth factor 21 (FGF21) plays an important role in the regulation of energy homeostasis during starvation and has an excellent therapeutic potential for the treatment of type 2 diabetes...

Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase

Sangwon Byun, Sunmi Seok, Young‐Chae Kim et al. · 2020 · Nature Communications · 205 citations

Depot fat as source of increased liver triglycerides after ethanol

M. G. Horning, Esther Williams, Harriet M. Maling et al. · 1960 · Biochemical and Biophysical Research Communications · 201 citations

Reading Guide

Foundational Papers

Start with Gälman et al. (2008, 491 citations) for human fasting/PPARα evidence, Lundåsen et al. (2007, 373 citations) for hepatic regulation mechanism, and Hondares et al. (2010, 362 citations) for developmental roles.

Recent Advances

Study Byun et al. (2020, 205 citations) for autophagy via JMJD3, Vernia et al. (2014, 184 citations) for JNK-PPARα axis, and Zhang et al. (2016, 157 citations) for fenofibrate cardioprotection.

Core Methods

Core techniques: PPARα agonists (fenofibrate), fasting/exercise models, hepatic FGF21 qPCR/ELISA, ChIP for promoter analysis, and mouse knockouts (Lundåsen 2007; Kim 2013; Cyphert 2012).

How PapersFlow Helps You Research FGF21 Metabolism Regulation

Discover & Search

Research Agent uses searchPapers('FGF21 PPARα hepatic regulation') to retrieve Gälman et al. (2008), then citationGraph reveals 491 citing papers on fasting induction, while findSimilarPapers expands to exercise contexts like Kim et al. (2013). exaSearch uncovers obscure FXR-FGF21 links from Cyphert et al. (2012).

Analyze & Verify

Analysis Agent applies readPaperContent on Liang et al. (2014) to extract gluconeogenesis mechanisms, then verifyResponse with CoVe cross-checks claims against Hondares et al. (2010). runPythonAnalysis plots fasting vs. exercise FGF21 levels from extracted data using pandas, with GRADE scoring evidence strength for PPARα pathways.

Synthesize & Write

Synthesis Agent detects gaps in neonatal vs. adult FGF21 regulation, flags contradictions between PPARα and JNK axes (Vernia et al., 2014), and uses exportMermaid for signaling diagrams. Writing Agent employs latexEditText for figure captions, latexSyncCitations for 10+ references, and latexCompile to generate a polished review section on therapeutic targets.

Use Cases

"Extract and plot FGF21 expression data from fasting and exercise papers"

Research Agent → searchPapers('FGF21 fasting exercise') → Analysis Agent → readPaperContent (Gälman 2008, Kim 2013) → runPythonAnalysis (pandas plot of expression levels vs. time/condition) → matplotlib figure of fold-changes.

"Draft LaTeX section on PPARα-FGF21 axis with citations"

Synthesis Agent → gap detection (Lundåsen 2007) → Writing Agent → latexEditText (intro paragraph) → latexSyncCitations (add Gälman 2008, Hondares 2010) → latexCompile → PDF section with equation for signaling cascade.

"Find code for FGF21 signaling simulations"

Research Agent → searchPapers('FGF21 simulation model') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis (test repo script on hepatic data from Byun 2020) → validated simulation output.

Automated Workflows

Deep Research workflow scans 50+ FGF21 papers via searchPapers → citationGraph → structured report on PPARα regulation with GRADE scores. DeepScan applies 7-step analysis: readPaperContent (Vernia 2014) → CoVe verification → runPythonAnalysis on JNK-FGF21 data → checkpoint critiques. Theorizer generates hypotheses on FXR-PPARα interplay from Cyphert (2012) and Lundåsen (2007).

Try Doxa for FGF21 Metabolism Regulation Research

Frequently Asked Questions

What defines FGF21 metabolism regulation?

FGF21 metabolism regulation involves PPARα-mediated hepatic expression during fasting, exercise, and ketogenic states to control lipid metabolism and glucose homeostasis (Gälman et al., 2008; Lundåsen et al., 2007).

What are key methods in FGF21 studies?

Methods include PPARα knockout models, fasting/exercise interventions in mice/humans, and ChIP assays for promoter binding (Hondares et al., 2010; Kim et al., 2013; Lundåsen et al., 2007).

What are foundational papers?

Gälman et al. (2008, 491 citations) shows human fasting induction; Lundåsen et al. (2007, 373 citations) proves PPARα regulation; Hondares et al. (2010, 362 citations) links to neonatal thermogenesis.

What open problems exist?

Challenges include translating rodent autophagy findings to humans (Byun et al., 2020), resolving tissue-specific signaling, and clinical validation of FGF21 agonists for diabetes (Liang et al., 2014).